Oric Pharmaceuticals's total assets for Q4 2024 were $274.14M, a decrease of -9.25% from the previous quarter. ORIC total liabilities were $31.02M for the fiscal quarter, a 10.49% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.